Patents by Inventor Bruce H. Levin

Bruce H. Levin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230127624
    Abstract: Disclosed herein are devices and methods for improved transnasal and transoral nasopharyngeal diagnostics and therapeutics, particularly to detect the presence of infectious agents such as a coronavirus, for example SARS-CoV-2, responsible for COVID-19, and other viral agents.
    Type: Application
    Filed: October 27, 2022
    Publication date: April 27, 2023
    Inventor: Bruce H Levin
  • Publication number: 20230028224
    Abstract: The present invention provides a method of patient care involving SPG blocking, pharmacotherapy or neuromodulation modalities.
    Type: Application
    Filed: September 30, 2022
    Publication date: January 26, 2023
    Inventor: Bruce H. Levin
  • Patent number: 11541237
    Abstract: Methods, apparatus, compositions and kits for inhibiting a disorder in a human patient, including non-cerebral neurovascular disorder or muscular headache pain, or loss of motor or sensory function, sympathetic tone or range or fluidity of motion that affect a nerve pathway at more than one locus associated with the disorder to inhibit the disorder. Alternatively or in addition, neuropathy associated with a disorder is treatable by palpating to determine a Keystone nerve essential to the neuropathy, applying pressure to determine a point of maximum discomfort or trigger of increased symptoms to identify a Levin Sign as a locus of initial intervention, and intervening to treat the neuropathy at the location of the Levin Sign by administering a pharmaceutically active agent, internal implanted or external neuro stimulation affecting the nerve pathway to inhibit the neuropathy.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: January 3, 2023
    Assignee: BHL PATENT HOLDINGS LLC
    Inventor: Bruce H Levin
  • Publication number: 20220305278
    Abstract: The present invention classifies disorders, including Local Anesthetic Responsive Headaches as a general class. The present invention also uses exclusion and inclusion criteria in order to better determine the proper treatment of disorders including dorsonasal targeted therapies.
    Type: Application
    Filed: June 15, 2022
    Publication date: September 29, 2022
    Inventor: Bruce H. Levin
  • Publication number: 20220310440
    Abstract: A drug delivery system includes flexible and interchangeable nozzle and tip. In one embodiment, the present invention relates to a medical device for intranasal delivery of a medicament. The present invention effectively delivers an appropriate amount of medicament to the designated surface area. In one other embodiment, the present invention ensures that a complete dosage of the medicament is delivered, especially to specific areas in the nasal cavity such as the rear of the nasal cavity where the SPG is located.
    Type: Application
    Filed: May 31, 2022
    Publication date: September 29, 2022
    Inventor: Bruce H. Levin
  • Publication number: 20220257946
    Abstract: Methods, apparatus, compositions and kits for inhibiting a disorder in a human patient, including non-cerebral neurovascular disorder or muscular headache pain, or loss of motor or sensory function, sympathetic tone or range or fluidity of motion that affect a nerve pathway at more than one locus associated with the disorder to inhibit the disorder. Alternatively or in addition, neuropathy associated with a disorder is treatable by palpating to determine a Keystone nerve essential to the neuropathy, applying pressure to determine a point of maximum discomfort or trigger of increased symptoms to identify a Levin Sign as a locus of initial intervention, and intervening to treat the neuropathy at the location of the Levin Sign by administering a pharmaceutically active agent, internal implanted or external neuro stimulation affecting the nerve pathway to inhibit the neuropathy.
    Type: Application
    Filed: August 15, 2018
    Publication date: August 18, 2022
    Inventor: Bruce H. Levin
  • Publication number: 20220152394
    Abstract: Methods, apparatus, compositions and kits for inhibiting a disorder in a human patient, including non-cerebral neurovascular disorder or muscular headache pain, or loss of motor or sensory function, sympathetic tone or range or fluidity of motion that affect a nerve pathway at more than one locus associated with the disorder to inhibit the disorder. Alternatively or in addition, neuropathy associated with a disorder is treatable by palpating to determine a Keystone nerve essential to the neuropathy, applying pressure to determine a point of maximum discomfort or trigger of increased symptoms to identify a Levin Sign as a locus of initial intervention, and intervening to treat the neuropathy at the location of the Levin Sign by administering a pharmaceutically active agent, internal implanted or external neuro stimulation affecting the nerve pathway to inhibit the neuropathy.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 19, 2022
    Inventor: Bruce H LEVIN
  • Patent number: 11266800
    Abstract: The present invention provides a drug delivery system that includes a housing configured to contain one or more dispensers. Each dispenser includes an activation mechanism, a nozzle configured to direct the medicament to a predetermined area in the nasal passageway. The nozzles may be configured to create a spray pattern that is about 50-degrees to direct the delivery of a medicament to the sphenopalatine ganglion.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: March 8, 2022
    Inventor: Bruce H. Levin
  • Publication number: 20210236162
    Abstract: The present invention presents a medical instrument for penetrating cutaneous and sub-cutaneous tissue, causing less hemorrhage and patient pain. This medical device for insertion into tissue comprising one or more section, said section including a plurality of facets; and each facet is configured to deflect the tissue it contacts in a direction that is different than adjacent facets.
    Type: Application
    Filed: April 14, 2021
    Publication date: August 5, 2021
    Inventor: Bruce H. Levin
  • Publication number: 20210074402
    Abstract: The present invention provides a method of patient care involving SPG blocking, pharmacotherapy or neuromodulation modalities.
    Type: Application
    Filed: September 8, 2020
    Publication date: March 11, 2021
    Inventor: Bruce H. Levin
  • Publication number: 20200246620
    Abstract: A method and device for treating a disorder by multiple points of stimulation.
    Type: Application
    Filed: January 31, 2020
    Publication date: August 6, 2020
    Inventor: Bruce H. Levin
  • Publication number: 20200054887
    Abstract: The present invention classifies disorders, including Local Anesthetic Responsive Headaches as a general class. The present invention also uses exclusion and inclusion criteria in order to better determine the proper treatment of disorders including dorsonasal targeted therapies.
    Type: Application
    Filed: August 26, 2019
    Publication date: February 20, 2020
    Inventor: Bruce H. Levin
  • Publication number: 20200054843
    Abstract: The present invention relates to a medical device for intranasal delivery of a medicament. The medicament may be any type of medicament suitable for nasal administration and delivery in the form of a spray. The present invention ensures that a complete dosage of the medicament is delivered, especially to specific areas in the nasal cavity, such as the rear of the nasal cavity where the SPG is located.
    Type: Application
    Filed: October 24, 2019
    Publication date: February 20, 2020
    Inventor: Bruce H. Levin
  • Publication number: 20200038562
    Abstract: The present invention provides implantable devices and related methods configured to stimulate, or otherwise modulate neural or other biological tissues or structures by implanting substance carrying devices and components such as micro-chips to promote, inhibit, alter, and otherwise affect and modulate the target structure's functionality, growth, expression, appearance and other features.
    Type: Application
    Filed: August 1, 2019
    Publication date: February 6, 2020
    Inventor: Bruce H. Levin
  • Publication number: 20200017603
    Abstract: A method comprising administering an agent, for example a PCSK9 inhibitor, to a patient who suffers from fatty liver disease or is at risk of fatty liver disease, thereby reducing the risk of fatty liver disease, severity of fatty liver disease, symptoms of such disease, or signs of such disease and a method comprising administering a PCSK9 inhibitor to a patient having symptoms of elevated liver enzymes to ameliorate said symptoms.
    Type: Application
    Filed: December 1, 2017
    Publication date: January 16, 2020
    Inventor: BRUCE H. LEVIN
  • Publication number: 20190333619
    Abstract: A system for tracking one or more drugs comprising a central database adapted to track a drug through its lifecycle from point of manufacture to use by a patient. The system is further adapted to recognize inconsistencies or patterns indicating illicit or improper use of a drug.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 31, 2019
    Inventor: Bruce H. Levin
  • Publication number: 20190216684
    Abstract: The present invention provides a HIPPA compliant monitoring system for drug distribution and decreasing drug diversion. Incorporating electromagnetic tag technology, such as RF ID and other applicable technology, a system is provided to track movements of a dispensed drug, from the manufacturer to the end use. A central unit processes information received from a number of different tracking units, stores such information and processes the information with pre-determined conditions including but not limited to drug abuse, diversion, and other compliance related events. Once an abnormal event is detected by the central unit, an alert may be sent to the authorities or relevant personnel. The system also includes a one or multilevel authentication code system, to further ensure the protection of a patient's privacy during the tracking process, and to make the system HIPPA compliant.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 18, 2019
    Inventor: Bruce H. Levin
  • Publication number: 20190217025
    Abstract: The present invention provides various medical instruments for delivery of nasal medication. It provides devices for influencing fluid flow around and/or inside a device. It also provides improved drug delivery systems to administer a desired dosage to the nasal epithelia, SPG, or a predetermined area.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 18, 2019
    Inventor: Bruce H. Levin
  • Publication number: 20190143054
    Abstract: The present invention provides a drug delivery system that includes a housing configured to contain one or more dispensers. Each dispenser includes an activation mechanism, a nozzle configured to direct the medicament to a predetermined area in the nasal passageway. The nozzles may be configured to create a spray pattern that is about 50-degrees to direct the delivery of a medicament to the sphenopalatine ganglion.
    Type: Application
    Filed: November 9, 2018
    Publication date: May 16, 2019
    Inventor: Bruce H. Levin
  • Publication number: 20190135927
    Abstract: Disclosed is method comprising administering anti-CGRP medications or monoclonal antibodies to CGRP and/or its receptors with neuroaugmentation to decrease pain associated with headache or chronic pain, for example migraine or cluster headache, or facial pain such as peripheral neuropathy.
    Type: Application
    Filed: September 28, 2018
    Publication date: May 9, 2019
    Inventor: BRUCE H. LEVIN